Bacterial artificial chromosome array-Based comparative genomic hybridization using paired formalin-fixed, paraffin-embedded and fresh frozen tissue specimens in multiple myeloma

Cancer

Volumn 115, Issue 2, 2009, Pages 345-354

  Lennon, Patrick A ^a   Zhuang, Yi ^a   Pierson, Diane ^a   Zhang, Xiang ^a   Williams, Chris ^b   Perez, Cintia ^a   Lin, Pei ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b PERKINELMER INC   (United States)

Author keywords

Array comparative genomic hybridization; Bacterial artificial chromosome; Formalin fixed; Multiple myeloma; Paraffin embedded

Indexed keywords

FORMALDEHYDE; FRESH FROZEN PLASMA; PARAFFIN;

ADULT; AGED; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; BONE MARROW BIOPSY; CHROMOSOME 13Q; CHROMOSOME 15Q; CHROMOSOME 19Q; CHROMOSOME 7Q; CHROMOSOME 8P; CHROMOSOME 9Q; CHROMOSOME ABERRATION; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; PRIORITY JOURNAL;

AGED; BONE MARROW CELLS; CHROMOSOME ABERRATIONS; CHROMOSOMES, ARTIFICIAL, BACTERIAL; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; FROZEN SECTIONS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PARAFFIN EMBEDDING; TISSUE ARRAY ANALYSIS;

EID: 59449090769     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24021     Document Type: Article

References (45)

1. Stewart AK, Fonseca R. Review of molecular diagnostics in multiple myeloma. Expert Rev Mol Diagn. 2007;7:453-459.
2. Campbell LJ. Conventional cytogenetics in myeloma. Methods Mol Med. 2005;113:37-47.
3. Mohamed AN, Bentley G, Bonnett ML, Zonder J, Al-Katib A. Chromosome aberrations in a series of 120 multiple myeloma cases with abnormal karyotypes. Am J Hematol. 2007;82:1080-1087.
4. Huang SY, Yao M, Tang JL, et al. Clinical significance of cytogenetics and interphase fluorescence in situ hybridization analysis in newly diagnosed multiple myeloma in Taiwan. Ann Oncol. 2005;16:1530-1538.
5. Cigudosa JC, Rao PH, Calasanz MJ, et al. Characterization of nonrandom chromosomal gains and losses in multiple myeloma by comparative genomic hybridization. Blood. 1998;91:3007-3010.
6. Gonzalez MB, Hernandez JM, Garcia JL, et al. The value of fluorescence in situ hybridization for the detection of 11q in multiple myeloma. Haematologica. 2004;89:1213-1218.
7. Cady FM, Muto DN, Ciabeterri G, Johns A, Gainey Church K, Wolff DJ. Utility of interphase FISH panels for routine clinical cytogenetic evaluation of chronic lympho-cytic leukemia and multiple myeloma. J Assoc Genet Technol. 2004;30:77-81.
8. Bignell GR, Huang J, Greshock J, et al. High-resolution analysis of DNA copy number using oligonucleotide micro-arrays. Genome Res. 2004;14:287-295.
9. Smadja NV, Leroux D, Soulier J, et al. Further cytogenetic characterization of multiple myeloma confirms that 14q32 translocations are a very rare event in hyperdiploid cases. Genes Chromosomes Cancer. 2003;38:234-239.
10. Gutierrez NC, Garcia JL, Hernandez JM, et al. Prognostic and biologic significance of chromosomal imbalances assessed by comparative genomic hybridization in multiple myeloma. Blood. 2004;104:2661-2666.
11. Shaffer LG, Bejjani BA. A cytogeneticist's perspective on genomic microarrays. Hum Reprod Update. 2004;10:221-226.
12. Lieu PT, Jozsi P, Gilles P, Peterson T. Development of a DNA-labeling system for array-based comparative genomic hybridization. J Biomol Tech. 2005;16:104-111.
13. Yu W, Ballif BC, Kashork CD, et al. Development of a comparative genomic hybridization microarray and demonstration of its utility with 25 well characterized 1p36 deletions. Hum Mol Genet. 2003;12:2145-2152.
14. Greshock J, Naylor TL, Margolin A, et al. 1-Mb resolution array-based comparative genomic hybridization using a BAC clone set optimized for cancer gene analysis. Genome Res. 2004;14:179-187.
15. Cai WW, Mao JH, Chow CW, Damani S, Balmain A, Bradley A. Genome-wide detection of chromosomal imbalances in tumors using BAC microarrays. Nat Biotechnol. 2002;20:393-396.
16. Largo C, Alvarez S, Saez B, et al. Identification of overexpressed genes in frequently gained/amplified chromosome regions in multiple myeloma. Haematologica. 2006;91:184-191.
17. Largo C, Saez B, Alvarez S, et al. Multiple myeloma primary cells show a highly rearranged unbalanced genome with amplifications and homozygous deletions irrespective of the presence of immunoglobulin-related chromosome translocations. Haematologica. 2007;92:795-802.
18. Wicker N, Carles A, Mills IG, et al. A new look towards BAC-based array CGH through a comprehensive comparison with oligo-based array CGH [serial online]. BMC Genomics. 2007;8:84.
19. Patel A, Kang SH, Lennon PA, et al. Validation of a targeted DNA microarray for the clinical evaluation of recurrent abnormalities in chronic lymphocytic leukemia. Am J Hematol. 2008;83:540-546.
20. Pollack JR, Perou CM, Alizadeh AA, et al. Genome-wide analysis of DNA copy-number changes using cDNA micro-arrays. Nat Genet. 1999;23:41-46.
21. Wessendorf S, Schwaenen C, Kohlhammer H, et al. Hidden gene amplifications in aggressive B-cell non-Hodgkin lymphomas detected by microarray-based comparative genomic hybridization. Oncogene. 2003;22:1425-1429.
22. Paris PL, Albertson DG, Alers JC, et al. High-resolution analysis of paraffin-embedded and formalin-fixed prostate tumors using comparative genomic hybridization to genomic microarrays. Am J Pathol. 2003;162:763-770.
23. Lassmann S, Weis R, Makowicc F, et al. Array CGH indentifies distinct DNA copy number profiles of onco-genes and tumor suppressor genes in chromosomal and microsatellite-unstable sporadic colorectal carcinomas. J Mol Med. 2007;85:293-304.
24. Devries S, Nyante S, Korkola J, et al. Array-based comparative genomic hybridization from formalin-fixed, paraffin-embedded breast tumors. J Mol Diagn. 2005;7:65-71.
25. 25.Little SE, Vuononvirta R, Reis-Filho JS, et al. Array CGH sing whole genome amplification of fresh-frozen and formalin-fixed, paraffin-embedded tumor DNA. Genomics. 2006;87:298-306.
26. Joosse SA, van Beers EH, Nederlof PM. Automated array-CGH optimized for archival formalin-fixed, paraffin-embedded tumor material [serial online]. BMC Cancer. 2007;7:43.
27. van Beers EH, Joosse SA, Ligtenberg MJ, et al. A multiplex PCR predictor for aCGH success of FFPE samples. Br J Cancer. 2006;94:333-337.
28. Paris PL, Sridharan S, Scheffer A, Tsalenko A, Bruhn L, Collins C. High resolution oligonucleotide CGH using DNA from archived prostate tissue. Prostate. 2007;67:1447-1455.
29. Oosting J, Lips EH, Van Eijk R, et al. High-resolution copy number analysis of paraffin-embedded archival tissue using SNP Bead Arrays. Genome Res. 2007;17:368-376.
30. Johnson NA, Hamoudi RA, Ichimura K, et al. Application of array CGH on archival formalin-fixed paraffin-embedded tissues including small numbers of microdissected cells. Lab Invest. 2006;86:968-978.
31. Mc Sherry EA, Mc Goldrick A, Kay EW, Hopkins AM, Gallagher WM, Dervan PA. Formalin-fixed paraffin-embedded clinical tissues show spurious copy number changes in array-CGH profiles. Clin Genet. 2007;72:441-447.
32. Cheung SW, Shaw CA, Yu W, et al. Development and validation of a CGH microarray for clinical cytogenetic diagnosis. Genet Med. 2005;7:422-432.
33. Lennon PA, Cooper ML, Curtis MA, et al. Array-based comparative genomic hybridization facilitates identification of breakpoints of a novel der(1)t(1;18)(p36.3;q23)dn in a child presenting with mental retardation. Am J Med Genet A. 2006;140:1156-1163.
34. Bejjani BA, Shaffer LG. Application of array-based comparative genomic hybridization to clinical diagnostics. J Mol Diagn. 2006;8:528-533.
35. Sandberg A. Cancer cytogenetics for clinicians. CA Cancer J Clin. 1994;44:136-159.
36. Ledbetter DH. Cytogenetic technology-genotype and phe-notype. N Engl J Med. 2008;359:1728-1730.
37. Heng HHQ, Spyropoulos B, Moens PB. FISH technology in chromosome and genome research. BioEssays. 1997;19:75-84.
38. Rao PH. Comparative genomic hybridization for analysis of changes in DNA copy number in multiple myeloma. Meth-ods Mol Med. 2005;113:71-83.
39. du Manoir S, Speicher MR, Joos S, et al. Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization. Hum Genet. 1993;90:590-610.
40. Hittelman A, Sridharan S, Roy R, et al. Evaluation of whole genome amplification protocols for array and oligo-nucleotide CGH. Diagn Mol Pathol. 2007;16:198-206.
41. Schmidt-Wolf IG, Glasmacher A, Hahn-Ast C, et al. Chromosomal aberrations in 130 patients with multiple myeloma studied by interphase FISH: diagnostic and prognostic relevance. Cancer Genet Cytogenet. 2006;167:20-25.
42. Avet-Loiseau H, Attal M, Moreau P, et al. Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome. Blood. 2007;109:3489-3495.
43. Carrasco DR, Tonon G, Huang Y, et al. High-resolution genomic profiles define distinct clinicopathogenetic subgroups of multiple myeloma patients. Cancer Cell. 2006;9:313-325.
44. Falluel-Morel A, Aubert N, Vaudry D, et al. Opposite regulation of the mitochondrial apoptotic pathway by C2-cer-amide and PACAP through a MAP-kinase-dependent mechanism in cerebellar granule cells. J Neurochem. 2004;91:1231-1243.
45. Chang JS, Santhanam R, Trotta R, et al. High levels of the BCR/ABL oncoprotein are required for the MAPK-hnRNP-E2 dependent suppression of C/EBPalpha-driven myeloid differentiation. Blood. 2007;110:994-1003.